Erratum. Hepatic CPT1A Facilitates Liver-Adipose Cross Talk via Induction of FGF21 in Mice. Diabetes 2022;71:31-42.
作者信息
Sun Wei, Nie Tao, Li Kuai, Wu Wenjie, Long Qiaoyun, Feng Tianshi, Mao Liufeng, Gao Yuan, Liu Qing, Gao Xuefei, Ye Dewei, Yan Kaixuan, Gu Ping, Xu Yong, Zhao Xuemei, Chen Kang, Loomes Kerry Martin, Lin Shaoqiang, Wu Donghai, Hui Xiaoyan
出版信息
Diabetes. 2022 Aug 1;71(8):1827. doi: 10.2337/db22-er08a.
Abstract
摘要
相似文献
1
Erratum. Hepatic CPT1A Facilitates Liver-Adipose Cross Talk via Induction of FGF21 in Mice. Diabetes 2022;71:31-42.勘误。肝脏中的CPT1A通过诱导小鼠体内的FGF21促进肝脏与脂肪组织的相互作用。《糖尿病》2022年；71卷：31 - 42页。
Diabetes. 2022 Aug 1;71(8):1827. doi: 10.2337/db22-er08a.
2
Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.肝酰基辅酶 A 去饱和酶 1 缺乏症通过 PGC-1α-FGF21 轴部分增加脂肪组织中的葡萄糖摄取。
J Biol Chem. 2019 Dec 20;294(51):19475-19485. doi: 10.1074/jbc.RA119.009868. Epub 2019 Nov 5.
3
Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.柚皮素可预防雄性小鼠肥胖、肝脂肪变性和葡萄糖不耐受，且不依赖成纤维细胞生长因子21。
Endocrinology. 2015 Jun;156(6):2087-102. doi: 10.1210/en.2014-2003. Epub 2015 Mar 16.
4
Identification of hepatic fibroblast growth factor 21 as a mediator in 17β-estradiol-induced white adipose tissue browning.鉴定肝成纤维细胞生长因子 21 为 17β-雌二醇诱导白色脂肪组织棕色化的介质。
FASEB J. 2018 Oct;32(10):5602-5611. doi: 10.1096/fj.201800240R. Epub 2018 May 2.
5
Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress.在肝癌发生和肝应激过程中，肝脏 FGF21 的激活。
BMC Gastroenterol. 2013 Apr 17;13:67. doi: 10.1186/1471-230X-13-67.
6
FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.FGF21 通过在长时间禁食期间介导肝脏和大脑之间的串扰来维持葡萄糖稳态。
Diabetes. 2014 Dec;63(12):4064-75. doi: 10.2337/db14-0541. Epub 2014 Jul 14.
7
Alcoholic fatty liver is blunted by rFGF21 administration in mice lacking adipose FGFR1: The role of FGF21 in PPARα-mediated regulation of adipose tissue mass.在缺乏脂肪组织FGFR1的小鼠中，给予重组FGF21可减轻酒精性脂肪肝：FGF21在PPARα介导的脂肪组织质量调节中的作用。
Biochem Biophys Res Commun. 2022 Sep 3;619:84-89. doi: 10.1016/j.bbrc.2022.05.099. Epub 2022 Jun 11.
8
Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner.甲状腺激素通过 PPARα 依赖性方式调节肝组织中纤维母细胞生长因子 21 的表达。
J Biol Chem. 2010 May 7;285(19):14078-82. doi: 10.1074/jbc.C110.107375. Epub 2010 Mar 17.
9
CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis.CREBH - FGF21轴通过抑制脂肪组织脂解作用改善肝脂肪变性。
Sci Rep. 2016 Jun 15;6:27938. doi: 10.1038/srep27938.
10
Nicotinamide riboside ameliorates high-fructose-induced lipid metabolism disorder in mice improving FGF21 resistance in the liver and white adipose tissue.烟酰胺核糖可改善高果糖诱导的小鼠脂代谢紊乱，提高肝脏和白色脂肪组织中 FGF21 的抵抗能力。
Food Funct. 2022 Nov 28;13(23):12400-12411. doi: 10.1039/d2fo01934e.
引用本文的文献
1
Unraveling the complexities of diet induced obesity and glucolipid dysfunction in metabolic syndrome.解析代谢综合征中饮食诱导的肥胖和糖脂功能障碍的复杂性。
Diabetol Metab Syndr. 2025 Jul 22;17(1):292. doi: 10.1186/s13098-025-01837-y.
2
High fat diet feeding impairs neutrophil phagocytosis, bacterial killing, and neutrophil-induced hematopoietic regeneration.高脂饮食会损害中性粒细胞的吞噬作用、细菌杀伤能力以及中性粒细胞诱导的造血再生。
J Immunol. 2025 Apr 1;214(4):680-693. doi: 10.1093/jimmun/vkaf024.
3
Adipokines regulate the development and progression of MASLD through organellar oxidative stress.脂肪因子通过细胞器氧化应激调节代谢相关脂肪性肝病的发生发展。
Hepatol Commun. 2025 Jan 29;9(2). doi: 10.1097/HC9.0000000000000639. eCollection 2025 Feb 1.
4
Thermogenic Fat as a New Obesity Management Tool: From Pharmaceutical Reagents to Cell Therapies.产热脂肪作为一种新的肥胖管理工具：从药物试剂到细胞疗法
Biomedicines. 2024 Jul 4;12(7):1474. doi: 10.3390/biomedicines12071474.
5
Berberine alleviates non-alcoholic hepatic steatosis partially by promoting SIRT1 deacetylation of CPT1A in mice.黄连素通过促进小鼠中CPT1A的SIRT1去乙酰化部分缓解非酒精性肝脂肪变性。
Gastroenterol Rep (Oxf). 2023 Jun 6;11:goad032. doi: 10.1093/gastro/goad032. eCollection 2023.
6
Mitochondrial CPT1A: Insights into structure, function, and basis for drug development.线粒体肉碱棕榈酰转移酶1A：结构、功能及药物开发基础的见解
Front Pharmacol. 2023 Mar 23;14:1160440. doi: 10.3389/fphar.2023.1160440. eCollection 2023.
7
MLN4924 Treatment Diminishes Excessive Lipid Storage in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease (NAFLD) by Stimulating Hepatic Mitochondrial Fatty Acid Oxidation and Lipid Metabolites.MLN4924治疗通过刺激肝脏线粒体脂肪酸氧化和脂质代谢产物减少高脂饮食诱导的非酒精性脂肪性肝病（NAFLD）中的过量脂质储存。
Pharmaceutics. 2022 Nov 15;14(11):2460. doi: 10.3390/pharmaceutics14112460.
8
Hepatic Hedgehog Signaling Participates in the Crosstalk between Liver and Adipose Tissue in Mice by Regulating FGF21.肝 Hedgehog 信号通过调节成纤维细胞生长因子 21 参与肝脏和脂肪组织在小鼠中的串扰。
Cells. 2022 May 18;11(10):1680. doi: 10.3390/cells11101680.
9
Inducible Systemic Deletion in Mice Leads to Transient Body Weight Loss upon Tamoxifen Treatment Associated with Decrease of Fat and Liver Glycogen Storage.诱导型系统性敲除小鼠在他莫昔芬处理后会出现短暂的体重减轻，伴随脂肪和肝脏糖原储存减少。
Int J Mol Sci. 2022 Mar 16;23(6):3201. doi: 10.3390/ijms23063201.
Zotero 插件